$APYP
APPYEA, INC

2019 Q1 Form 10-Q Financial Statement

#000164033419000285 Filed on February 19, 2019

View on sec.gov

Income Statement

Concept 2019 Q1 2018 Q4 2017 Q4
Revenue $92.00 $119.00 $110.00
YoY Change -99.22% 8.18% -20.86%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $40.00K $50.00K $200.0K
YoY Change -69.23% -75.0% 66.67%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $7.936K
YoY Change -100.0% -100.0% -27.13%
% of Gross Profit
Operating Expenses $38.08K $45.02K $210.8K
YoY Change -72.08% -78.64% 65.05%
Operating Profit -$37.99K -$44.90K -$210.7K
YoY Change -69.5% -78.68% 65.14%
Interest Expense $54.56K -$34.13K $111.1K
YoY Change -51.69% -130.72% 1755.07%
% of Operating Profit
Other Income/Expense, Net -$2.850M $452.0K -$326.9K
YoY Change 945.73% -238.28% 6610.14%
Pretax Income -$2.890M $410.0K -$540.0K
YoY Change 622.5% -175.93% 315.38%
Income Tax
% Of Pretax Income
Net Earnings -$2.888M $407.1K -$537.5K
YoY Change 627.24% -175.73% 305.87%
Net Earnings / Revenue -3138917.39% 342063.03% -488646.36%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share -$0.22 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 2.150B shares 1.331B shares 945.0M shares
Diluted Shares Outstanding 7.173B shares 945.0M shares

Balance Sheet

Concept 2019 Q1 2018 Q4 2017 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $90.00K $0.00 $10.00K
YoY Change -100.0% 0.0%
Cash & Equivalents $86.34K $2.064K $10.09K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $86.34K $2.064K $10.09K
YoY Change 569.32% -79.54% -80.26%
LONG-TERM ASSETS
Property, Plant & Equipment $800.00 $800.00 $20.30K
YoY Change -94.2% -96.06% -66.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $25.00K
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $800.00 $800.00 $45.30K
YoY Change -97.91% -98.23% -25.32%
TOTAL ASSETS
Total Short-Term Assets $86.34K $2.064K $10.09K
Total Long-Term Assets $800.00 $800.00 $45.30K
Total Assets $87.14K $2.864K $55.39K
YoY Change 70.11% -94.83% -50.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $270.0K $270.0K $100.0K
YoY Change 35.0% 170.0% 1881.38%
Accrued Expenses $1.869K $270.0K $180.0K
YoY Change -99.07% 50.0% 125.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $280.0K $350.0K $110.0K
YoY Change 33.33% 218.18% 0.0%
Total Short-Term Liabilities $3.739M $1.539M $911.4K
YoY Change 194.33% 68.86% 333.77%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.739M $1.539M $911.4K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $3.739M $1.539M $911.4K
YoY Change 194.33% 68.86% 333.77%
SHAREHOLDERS EQUITY
Retained Earnings -$9.475M -$6.588M -$5.727M
YoY Change 54.72% 15.03% 34.47%
Common Stock $381.3K $162.3K $109.2K
YoY Change 226.34% 48.59% 132.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.651M -$1.536M -$856.0K
YoY Change
Total Liabilities & Shareholders Equity $87.14K $2.864K $55.39K
YoY Change 70.11% -94.83% -50.44%

Cashflow Statement

Concept 2019 Q1 2018 Q4 2017 Q4
OPERATING ACTIVITIES
Net Income -$2.888M $407.1K -$537.5K
YoY Change 627.24% -175.73% 305.87%
Depreciation, Depletion And Amortization $0.00 $0.00 $7.936K
YoY Change -100.0% -100.0% -27.13%
Cash From Operating Activities -$10.00K -$30.00K -$80.00K
YoY Change 0.0% -62.5% 0.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$30.00K
YoY Change
Cash From Investing Activities -$30.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 90.00K 0.000 110.0K
YoY Change -100.0% 22.22%
NET CHANGE
Cash From Operating Activities -10.00K -30.00K -80.00K
Cash From Investing Activities -30.00K
Cash From Financing Activities 90.00K 0.000 110.0K
Net Change In Cash 80.00K -30.00K 0.00000000001455
YoY Change -900.0% -206158430208000100.0% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$10.00K -$30.00K -$80.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
apyp Class Of Warrant Or Right Weighted Average Exercise Price Forfeited Or Canceled
ClassOfWarrantOrRightWeightedAverageExercisePriceForfeitedOrCanceled
0.0000
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2150441260 shares
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2018-12-31
dei Entity Registrant Name
EntityRegistrantName
APPYEA, INC
dei Entity Central Index Key
EntityCentralIndexKey
0001568969
dei Trading Symbol
TradingSymbol
apyp
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
42567 usd
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47196 usd
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2064 usd
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
10087 usd
CY2018Q2 us-gaap Assets Current
AssetsCurrent
47196 usd
CY2018Q4 us-gaap Assets Current
AssetsCurrent
2064 usd
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7300 usd
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
800 usd
CY2018Q2 us-gaap Assets
Assets
54496 usd
CY2018Q4 us-gaap Assets
Assets
2864 usd
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
275312 usd
CY2018Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
270221 usd
CY2018Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
224000 usd
CY2018Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
272000 usd
CY2018Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
290823 usd
CY2018Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
337531 usd
CY2018Q2 apyp Convertible Debt Related Party
ConvertibleDebtRelatedParty
8977 usd
CY2018Q4 apyp Convertible Debt Related Party
ConvertibleDebtRelatedParty
9999 usd
CY2018Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
88087 usd
CY2018Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
82689 usd
CY2018Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
1016865 usd
CY2018Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
566519 usd
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1904064 usd
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1538959 usd
CY2018Q2 us-gaap Liabilities
Liabilities
1904064 usd
CY2018Q4 us-gaap Liabilities
Liabilities
1538959 usd
CY2018Q2 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
500 usd
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
124047 usd
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
162313 usd
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4740277 usd
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4826005 usd
CY2018Q2 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
62727 usd
CY2018Q4 apyp Stock Payable Common Shares Value
StockPayableCommonSharesValue
62727 usd
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6777119 usd
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6587640 usd
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-1849568 usd
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-1536095 usd
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54496 usd
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2864 usd
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
250570 usd
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
257070 usd
CY2018Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
81968 usd
CY2018Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
37095 usd
CY2018Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
60000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
60000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
5000000 shares
CY2018Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
5000000 shares
CY2018Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
6000000000 shares
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1240477060 shares
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1623141260 shares
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1240477060 shares
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1623141260 shares
CY2017Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
110 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1044 usd
CY2018Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
119 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
197 usd
CY2017Q4 us-gaap Professional Fees
ProfessionalFees
164974 usd
us-gaap Professional Fees
ProfessionalFees
229804 usd
CY2018Q4 us-gaap Professional Fees
ProfessionalFees
18610 usd
us-gaap Professional Fees
ProfessionalFees
28171 usd
CY2017Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
37860 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
135096 usd
CY2018Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26412 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
54669 usd
CY2017Q4 us-gaap Depreciation
Depreciation
7936 usd
us-gaap Depreciation
Depreciation
18744 usd
us-gaap Depreciation
Depreciation
6500 usd
CY2017Q4 us-gaap Operating Expenses
OperatingExpenses
210770 usd
us-gaap Operating Expenses
OperatingExpenses
383644 usd
CY2018Q4 us-gaap Operating Expenses
OperatingExpenses
45022 usd
us-gaap Operating Expenses
OperatingExpenses
89340 usd
CY2017Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-210660 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-382600 usd
CY2018Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-44903 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-89143 usd
CY2017Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-215751 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-349988 usd
CY2018Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
486086 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
355325 usd
CY2017Q4 us-gaap Interest Expense
InterestExpense
111100 usd
us-gaap Interest Expense
InterestExpense
211556 usd
CY2018Q4 us-gaap Interest Expense
InterestExpense
34128 usd
us-gaap Interest Expense
InterestExpense
76703 usd
CY2018Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
290823 usd
CY2018Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
337531 usd
CY2017Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-326851 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-561544 usd
CY2018Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
451958 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
278622 usd
CY2017Q4 us-gaap Net Income Loss
NetIncomeLoss
-537511 usd
us-gaap Net Income Loss
NetIncomeLoss
-944144 usd
CY2018Q4 us-gaap Net Income Loss
NetIncomeLoss
407055 usd
us-gaap Net Income Loss
NetIncomeLoss
189479 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
171514 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
44873 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
95196 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5091 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
48000 usd
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
48000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
40043 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
31830 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-121159 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39734 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
200 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
20050 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
4196 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
6571 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
9594 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
113679 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-5398 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-32480 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-45132 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
145039 usd
apyp Issuance Of Common Stock For Conversion Of Debt And Accrued Interest
IssuanceOfCommonStockForConversionOfDebtAndAccruedInterest
28973 usd
us-gaap Notes Reduction
NotesReduction
258603 usd
us-gaap Notes Reduction
NotesReduction
95021 usd
apyp Derivative Liability Recognized As Debt Discount
DerivativeLiabilityRecognizedAsDebtDiscount
235000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Nature Of Operations
NatureOfOperations
<div> <p align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>1. NATURE OF OPERATIONS</b></p> <p align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">AppYea, Inc. ("AppYea", "the Company", "we" or "us") was incorporated in the State of South Dakota on November 26, 2012 to engage in the acquisition, purchase, maintenance and creation of mobile software applications. The Company is in the development stage with no significant revenues and a limited operating history.</p> <p align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company incorporated a wholly-owned subsidiary, &#8220;AppYea Holdings, Inc.&#8221; in state of South Dakota on January 13, 2017 and "The Diagnostic Centers Inc." in State of South Dakota on August 2, 2017.</p> <p align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <p align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">Through its wholly owned subsidiary, The Diagnostic Centers, Inc., AppYea markets comprehensive diagnostic testing services to physician offices, clinics, hospitals, long term care facilities, healthcare groups, and other healthcare providers.</p> <p align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <div align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The Company's common stock is traded on the OTC Markets&#160;(www.otcmarkets.com) under the symbol "APYP". The first day of trading on the OTC Markets was December 15, 2014.</div> </div>
CY2018Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2018Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2018Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0004
apyp Class Of Warrant Or Right Weighted Average Exercise Price Granted
ClassOfWarrantOrRightWeightedAverageExercisePriceGranted
0.0000
apyp Class Of Warrant Or Right Weighted Average Exercise Price With Reset Feature
ClassOfWarrantOrRightWeightedAverageExercisePriceWithResetFeature
0.0000
apyp Class Of Warrant Or Right Weighted Average Exercise Price Exercised
ClassOfWarrantOrRightWeightedAverageExercisePriceExercised
0.0000
CY2018Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
592916818 shares
us-gaap Use Of Estimates
UseOfEstimates
<div> <p align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;"><b>Use of Estimates</b></p> <p align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">&#160;</p> <div align="justify" style="margin: 0px 0px 0px 0in; text-align: justify; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; font-family: 'times new roman'; font-size: 13.33px; font-style: normal; font-weight: 400; word-spacing: 0px; white-space: normal; orphans: 2; widows: 2; font-variant-ligatures: normal; font-variant-caps: normal; -webkit-text-stroke-width: 0px; text-decoration-style: initial; text-decoration-color: initial;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include assumptions about the valuation and recognition of stock-based compensation expense, the valuation and recognition of derivative liability, valuation allowance for deferred tax assets and useful life of fixed assets.</div> </div>
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
592916818 shares
apyp Class Of Warrant Or Right Granted
ClassOfWarrantOrRightGranted
0 shares
apyp Class Of Warrant Or Right With Reset Feature
ClassOfWarrantOrRightWithResetFeature
0 shares
apyp Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
apyp Class Of Warrant Or Right Forfeited Or Cancellation
ClassOfWarrantOrRightForfeitedOrCancellation
0 shares
CY2018Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.0004
CY2018Q4 apyp Working Capital Surplus Deficit
WorkingCapitalSurplusDeficit
-1536895 usd
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
257870 usd
CY2018Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
345614 usd
CY2018Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
338996 usd
CY2018Q2 us-gaap Interest Payable Current
InterestPayableCurrent
27177 usd
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
35630 usd
CY2018Q2 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
290823 usd
CY2018Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
337531 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
169442 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
44873 usd
CY2018Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
78947 usd
CY2018Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
28973 usd
CY2018Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0500 pure
CY2018Q2 us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
20 day
CY2018Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.0002
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
382664200 shares
us-gaap Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt
AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt
95021 usd
CY2018 us-gaap Debt Instrument Term
DebtInstrumentTerm
P6M
CY2018Q4 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
116666 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
142167 usd
CY2018Q2 apyp Class Of Warrant Or Right Exercisable Of Common Stock Shares
ClassOfWarrantOrRightExercisableOfCommonStockShares
394735000 shares
CY2018Q2 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
9371 usd
us-gaap Derivative Loss On Derivative
DerivativeLossOnDerivative
1038 usd
CY2018Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
8333 usd
CY2018Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
8333 usd
CY2018Q2 us-gaap Notes Payable
NotesPayable
8333 usd
CY2018Q4 us-gaap Notes Payable
NotesPayable
8333 usd
CY2018Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
644 usd
CY2018Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
1666 usd
CY2018Q2 apyp Debt Instrument Unamortized Discount Related Party Current
DebtInstrumentUnamortizedDiscountRelatedPartyCurrent
0 usd
CY2018Q4 apyp Debt Instrument Unamortized Discount Related Party Current
DebtInstrumentUnamortizedDiscountRelatedPartyCurrent
0 usd
CY2018Q2 apyp Convertible Debt Related Party Current And Noncurrent
ConvertibleDebtRelatedPartyCurrentAndNoncurrent
8977 usd
CY2018Q4 apyp Convertible Debt Related Party Current And Noncurrent
ConvertibleDebtRelatedPartyCurrentAndNoncurrent
9999 usd
CY2018Q2 apyp Convertible Debt Related Party Noncurrent
ConvertibleDebtRelatedPartyNoncurrent
0 usd
CY2018Q4 apyp Convertible Debt Related Party Noncurrent
ConvertibleDebtRelatedPartyNoncurrent
0 usd
CY2018 apyp Proceeds From Convertible Notes Payable Related Party Net Of Original Issue Discounts
ProceedsFromConvertibleNotesPayableRelatedPartyNetOfOriginalIssueDiscounts
8333 usd
CY2018 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.08 pure
CY2018 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.45 pure
CY2018Q4 apyp Value Assigned To Derivative Liability Recognized As Debt Discount
ValueAssignedToDerivativeLiabilityRecognizedAsDebtDiscount
8333 usd
us-gaap Increase Decrease In Derivative Liabilities
IncreaseDecreaseInDerivativeLiabilities
-355325 usd
CY2013Q1 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
200 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1238 usd
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
1246 usd
CY2013Q1 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P3M
CY2013Q1 us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
three-month periods unless there is the notice to cancel. The lease can be cancelled at any time by either party with 30 days' notice prior to expiration of an applicable term.
CY2018 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
30000000 shares
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
200 usd
CY2018 apyp Stock Issued Period For Common Stock Payable
StockIssuedPeriodForCommonStockPayable
57273 usd
CY2018Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
1500 shares
us-gaap Preferred Stock Voting Rights
PreferredStockVotingRights
voting rights of 1,000 shares of common stock
CY2017Q2 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
55000000 shares
CY2018Q4 apyp Stock Issued During Period Shares Issuable For Consulting Services
StockIssuedDuringPeriodSharesIssuableForConsultingServices
25000000 shares
CY2017Q2 apyp Stock Payable To Consulting Services Common Shares Value
StockPayableToConsultingServicesCommonSharesValue
105000 usd
CY2018Q4 apyp Stock Payable To Consulting Services Common Shares Value
StockPayableToConsultingServicesCommonSharesValue
47727 usd
apyp Derivative Liabilities Settled On Issuance Of Common Stock
DerivativeLiabilitiesSettledOnIssuanceOfCommonStock
-95021 usd
CY2017Q4 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
0 usd
CY2018Q4 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-451958 usd
us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
-278622 usd
CY2017Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-537511 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-944144 usd
CY2018Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-44903 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-89143 usd
CY2017Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
944991968 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
805777397 shares
CY2018Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1330983536 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
1285730298 shares
CY2017Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2018Q4 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
5614029126 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
5614029126 shares
CY2017Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
944991968 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
805777397 shares
CY2018Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7173042878 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7148481669 shares
CY2017Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2018Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2017Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2018Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
apyp Original Issue Discounts And Financing Costs
OriginalIssueDiscountsAndFinancingCosts
38447 usd
apyp Common Stock Issued For Services
CommonStockIssuedForServices
99500 usd
apyp Proceeds From Convertible Notes Payable Net Of Original Issue Discounts
ProceedsFromConvertibleNotesPayableNetOfOriginalIssueDiscounts
91667 usd
apyp Proceeds From Convertible Notes Payable Related Party
ProceedsFromConvertibleNotesPayableRelatedParty
8333 usd
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
25000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000 usd
CY2017Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
0 shares
CY2018Q4 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
228030216 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
248722245 shares

Files In Submission

Name View Source Status
0001640334-19-000285-index-headers.html Edgar Link pending
0001640334-19-000285-index.html Edgar Link pending
0001640334-19-000285.txt Edgar Link pending
0001640334-19-000285-xbrl.zip Edgar Link pending
apyp-20181231.xsd Edgar Link pending
apyp_10q.htm Edgar Link pending
apyp_ex311.htm Edgar Link pending
apyp_ex321.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
apyp-20181231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
apyp-20181231_lab.xml Edgar Link unprocessable
apyp-20181231_pre.xml Edgar Link unprocessable
apyp-20181231.xml Edgar Link completed
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
apyp-20181231_cal.xml Edgar Link unprocessable